Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

NCT06062745 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Prostate Cancer
Metastatic Prostate Cancer
Metastatic Prostate Neuroendocrine Carcinoma

Interventions

DRUG: 18F-fluciclovine
DEVICE: PET/CT

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]